HCA Healthcare Long-Term Investments 2012-2026 | HCA
HCA Healthcare long-term investments from 2012 to 2026. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- HCA Healthcare long-term investments for the quarter ending March 31, 2026 were $1.118B, a 9.18% decline year-over-year.
- HCA Healthcare long-term investments for 2025 were $1.118B, a 9.18% decline from 2024.
- HCA Healthcare long-term investments for 2024 were $1.231B, a 0.16% decline from 2023.
- HCA Healthcare long-term investments for 2023 were $1.233B, a 2.41% increase from 2022.
|
HCA Healthcare Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025 | $1,118 |
| 2024 | $1,231 |
| 2023 | $1,233 |
| 2022 | $1,204 |
| 2021 | $886 |
| 2020 | $810 |
| 2019 | $564 |
| 2018 | $594 |
| 2017 | $617 |
| 2016 | $542 |
| 2015 | $610 |
| 2014 | $659 |
| 2013 | $569 |
| 2012 | $619 |
| 2011 | $649 |
|
HCA Healthcare Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025-12-31 | $1,118 |
| 2025-09-30 | $1,227 |
| 2025-06-30 | $1,185 |
| 2025-03-31 | $1,207 |
| 2024-12-31 | $1,231 |
| 2024-09-30 | $1,258 |
| 2024-06-30 | $1,185 |
| 2024-03-31 | $1,207 |
| 2023-12-31 | $1,233 |
| 2023-09-30 | $1,121 |
| 2023-06-30 | $1,115 |
| 2023-03-31 | $1,176 |
| 2022-12-31 | $1,204 |
| 2022-09-30 | $816 |
| 2022-06-30 | $814 |
| 2022-03-31 | $849 |
| 2021-12-31 | $886 |
| 2021-09-30 | $830 |
| 2021-06-30 | $792 |
| 2021-03-31 | $820 |
| 2020-12-31 | $810 |
| 2020-09-30 | $725 |
| 2020-06-30 | $639 |
| 2020-03-31 | $563 |
| 2019-12-31 | $564 |
| 2019-09-30 | $600 |
| 2019-06-30 | $589 |
| 2019-03-31 | $584 |
| 2018-12-31 | $594 |
| 2018-09-30 | $605 |
| 2018-06-30 | $648 |
| 2018-03-31 | $648 |
| 2017-12-31 | $617 |
| 2017-09-30 | $569 |
| 2017-06-30 | $549 |
| 2017-03-31 | $543 |
| 2016-12-31 | $542 |
| 2016-09-30 | $570 |
| 2016-06-30 | $542 |
| 2016-03-31 | $599 |
| 2015-12-31 | $610 |
| 2015-09-30 | $595 |
| 2015-06-30 | $586 |
| 2015-03-31 | $616 |
| 2014-12-31 | $659 |
| 2014-09-30 | $608 |
| 2014-06-30 | $576 |
| 2014-03-31 | $595 |
| 2013-12-31 | $569 |
| 2013-09-30 | $527 |
| 2013-06-30 | $525 |
| 2013-03-31 | $530 |
| 2012-12-31 | $619 |
| 2012-09-30 | $576 |
| 2012-06-30 | $597 |
| 2012-03-31 | $644 |
| 2011-12-31 | $649 |
| 2011-09-30 | $1,382 |
| 2011-06-30 | $1,358 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $110.772B | $75.600B |
| HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |